InVision builds AI software for echocardiography interpretation, reporting, and disease screening. Its products process standard DICOM echo studies to automate ejection fraction measurement, detect cardiac amyloidosis, screen for cirrhosis and steatotic liver disease, and draft structured reports. The company cites FDA clearances, peer-reviewed research in Nature, JAMA Cardiology, NEJM AI, and JACC, and deployments with health systems through partners such as HeartLab.
Founder
41 Madison Ave flr 25, New York, New York 10010, United States
InVision Medical Technology primarily focuses on the healthcare industry, specifically in the field of medical technology related to cardiology. They develop AI tools aimed at improving the interpretation of heart ultrasounds and identifying undiagnosed diseases.
InVision Medical Technology operates in the AI healthcare sector, specifically focusing on the interpretation of heart ultrasounds. Its main competitors include:
Siemens Healthcare GmbH: A major player in medical imaging, Siemens offers advanced ultrasound systems integrated with AI capabilities for enhanced diagnostic accuracy.
General Electric Company (GE Healthcare): GE provides a range of ultrasound solutions that utilize AI to improve image quality and diagnostic efficiency, making it a strong competitor in the market.
Philips Healthcare: Known for its innovative imaging technologies, Philips integrates AI into its ultrasound systems to assist in disease detection and improve workflow.
Arterys Inc.: This company specializes in cloud-based AI solutions for medical imaging, including cardiac imaging, which directly competes with InVision's offerings.
Aidoc: Focused on AI solutions for radiology, Aidoc provides tools that assist in the interpretation of medical images, including ultrasound, enhancing diagnostic capabilities.
Qure.ai: This company develops AI algorithms for various imaging modalities, including ultrasound, aimed at improving diagnostic accuracy and efficiency.
Notable differences or advantages: